IMPACCT Real-World Evidence Summit

The IMPACCT Real-World Evidence Summit took place at the Hilton Boston Logan Airport, bringing together a diverse group of industry professionals to explore the advancements and challenges in real-world evidence (RWE) and its applications in drug development. This summit served as a critical platform for delegates to enhance their strategies in utilizing RWE across various stages of the drug development lifecycle, including clinical research, regulatory submissions, payer negotiations, and market access. With the recent changes in guidance from the Centers for Medicare & Medicaid Services (CMS) and the establishment of the FDA's RWE Center, there is a growing focus on harnessing RWE for regulatory decision-making, making the summit timely and relevant.Attendees had the opportunity to engage with experts from leading pharmaceutical companies and vendors, gaining insights through firsthand case studies that emphasized the importance of data quality and the validation of AI and predictive modeling in data analysis. The summit featured a range of speakers including Executive Directors and Senior Directors from various fields such as Epidemiology, Real-World Science, Biostatistics, Health Economics, and Outcomes Research, all of whom shared their knowledge and experiences in the health data landscape. The event's agenda included state-of-the-art presentations, interactive roundtables, and panel discussions aimed at addressing the current challenges in evidence generation. Networking sessions allowed participants to connect with peers and leaders in the field, fostering collaboration and discussion on the latest industry breakthroughs. Overall, the IMPACCT Real-World Evidence Summit is a pivotal event for professionals looking to advance their understanding and application of RWE in the biopharmaceutical sector.